352 related articles for article (PubMed ID: 30383109)
1. Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.
Naik RP; Smith-Whitley K; Hassell KL; Umeh NI; de Montalembert M; Sahota P; Haywood C; Jenkins J; Lloyd-Puryear MA; Joiner CH; Bonham VL; Kato GJ
Ann Intern Med; 2018 Nov; 169(9):619-627. PubMed ID: 30383109
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.
Olaniran KO; Eneanya ND; Allegretti AS; Zhao SH; Achebe MM; Thadhani RI
Am J Nephrol; 2019; 49(2):93-102. PubMed ID: 30625463
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis in a Sickle Cell Trait Positive Active Duty Male Soldier.
Saxena P; Chavarria C; Thurlow J
US Army Med Dep J; 2016; ():20-3. PubMed ID: 26874092
[TBL] [Abstract][Full Text] [Related]
5. Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach?
Makaryus JN; Catanzaro JN; Katona KC
Hematology; 2007 Aug; 12(4):349-52. PubMed ID: 17654064
[TBL] [Abstract][Full Text] [Related]
6. Sickle Cell Trait, Rhabdomyolysis, and Mortality among U.S. Army Soldiers.
Nelson DA; Deuster PA; Carter R; Hill OT; Wolcott VL; Kurina LM
N Engl J Med; 2016 Aug; 375(5):435-42. PubMed ID: 27518662
[TBL] [Abstract][Full Text] [Related]
7. Exertional Rhabdomyolysis and Sickle Cell Trait Status in the U.S. Air Force, January 2009-December 2018.
Webber BJ; Nye NS; Covey CJ; Harmon KG; Ruiz SA; O'Connor FG
MSMR; 2021 Jan; 28(1):15-19. PubMed ID: 33523681
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy in sickle cell trait: what we do and don't know.
Wilson S; Ellsworth P; Key NS
Br J Haematol; 2020 Aug; 190(3):328-335. PubMed ID: 32064587
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Analysis of Exertional Rhabdomyolysis in Sickle Cell Trait Positive African Americans.
Ren M; Sambuughin N; Mungunshukh O; Edgeworth DB; Hupalo D; Zhang X; Wilkerson MD; Dalgard CL; O'Connor FG; Deuster PA
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674343
[TBL] [Abstract][Full Text] [Related]
10. Association Between Sickle Cell Trait With Selected Chronic Medical Conditions in U.S. Service Members.
Niebuhr DW; Chen L; Shao S; Goldsmith J; Byrne C; Singer DE
Mil Med; 2018 Nov; 183(11-12):e735-e740. PubMed ID: 29889287
[TBL] [Abstract][Full Text] [Related]
11. Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory.
Key NS; Connes P; Derebail VK
Br J Haematol; 2015 Jul; 170(1):5-14. PubMed ID: 25754217
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of kidney donors with sickle cell trait: A preliminary analysis.
Hebert SA; Gandhi NV; Al-Amin S; Edwards AR; Murad DN; Nguyen DT; Graviss EA; Ibrahim HN
Clin Transplant; 2022 Jun; 36(6):e14626. PubMed ID: 35218242
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell trait and fatal rhabdomyolysis in football training: a case study.
Anzalone ML; Green VS; Buja M; Sanchez LA; Harrykissoon RI; Eichner ER
Med Sci Sports Exerc; 2010 Jan; 42(1):3-7. PubMed ID: 20010136
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
Thromb J; 2018; 16():27. PubMed ID: 30305805
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Exertional rhabdomyolysis in a spin class participant with sickle cell trait.
Longo T; Shaines M
F1000Res; 2018; 7():1742. PubMed ID: 31372209
[TBL] [Abstract][Full Text] [Related]
16. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sickle Cell Trait on Total Hip Arthroplasty in a Matched Cohort.
Waters TL; Wilder JH; Ross BJ; Salas Z; Sherman WF
J Arthroplasty; 2022 May; 37(5):892-896.e5. PubMed ID: 35026366
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell trait: what are the costs and benefits of screening?
Shephard RJ
J Sports Med Phys Fitness; 2016 Dec; 56(12):1562-1573. PubMed ID: 26842866
[TBL] [Abstract][Full Text] [Related]
19. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
